Posted on October 18th, 2011 by
A federal health panel unanimously voted Monday that a drug for Parkinson's disease from Teva Pharmaceuticals has not been shown to slow progress of the debilitating neurological disease. Teva's drug Azilect is already approved to treat symptoms of Parkinson's, which causes tremors, muscle stiffness and a host of other movement problems… "In medical science, things have to make sense, and they have to be consistent," said Dr. Eric Ahlskog of the Mayo Clinic, explaining his vote against the drug.
NPR (AP), 10/18/11
Additional coverage: Canadian Business
You must be logged-in to the site to post a comment.